Brain MRI iron deposition and serum iron with multiple sclerosis: Evidence from a Mendelian randomization study
Authors:
- 10 April 2026
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 114, 103443
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation (2025M772307)
- Peking University First Hospital
This publication has 52 references indexed in Scilit:
- Shared genetics and causal associations between COVID‐19 and multiple sclerosisJournal of Medical Virology, 2022
- Iron Heterogeneity in Early Active Multiple Sclerosis LesionsAnnals of Neurology, 2020
- Depression and prostate cancer risk: A Mendelian randomization studyCancer Medicine, 2020
- Association of Chronic Active Multiple Sclerosis Lesions With Disability In VivoJAMA Neurology, 2019
- Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patientsMovement Disorders, 2018
- Mendelian RandomizationJAMA, 2017
- Overview of quantitative susceptibility mappingNMR in Biomedicine, 2016
- Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI studyJournal of Magnetic Resonance Imaging, 2014
- Iron and neurodegeneration in the multiple sclerosis brainAnnals of Neurology, 2013
- MRI assessment of iron deposition in multiple sclerosisJournal of Magnetic Resonance Imaging, 2011